Helen of Troy (NASDAQ:HELE – Get Free Report) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 7.150-7.400 for the period, compared to the consensus estimate of 7.210. The company issued revenue guidance of $1.9 billion-$1.9 billion, compared to the consensus revenue estimate […]

AngioDynamics (NASDAQ:ANGO – Get Free Report) updated its FY25 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of ($0.38)-($0.34) for the period, compared to the consensus estimate of ($0.40). The company issued revenue guidance of $282-288 million, compared to the consensus revenue estimate of $283.86 million. AngioDynamics also updated its FY […]

Halozyme Therapeutics (NASDAQ:HALO – Get Free Report) issued an update on its FY 2024 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 4.000-4.200 for the period, compared to the consensus earnings per share estimate of 4.140. The company issued revenue guidance of $970.0 million-$1.0 billion, compared to the consensus revenue […]